Kalaris Therapeutics, Inc. (KLRS)

4.135 +0.04 (+0.85%) USD  |  NASDAQ  |  Aug 25, 15:41
More

Kalaris Therapeutics Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for KLRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2025. Start Trial.
Date Value
August 11, 2026 --
July 17, 2026 --
June 15, 2026 --
May 14, 2026 --
May 13, 2026 --
May 12, 2026 --
March 31, 2026 --
March 18, 2026 --
March 17, 2026 --
March 09, 2026 --
February 17, 2026 --
January 09, 2026 --
January 07, 2026 --
December 18, 2025 --
November 25, 2025 --
Date Value
November 17, 2025 --
November 12, 2025 --
November 11, 2025 --
November 03, 2025 --
September 15, 2025 --
September 02, 2025 --
August 14, 2025 --
August 13, 2025 --
July 23, 2025 --
July 11, 2025 --
July 10, 2025 --
May 19, 2025 --
May 14, 2025 --
May 07, 2025 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Replimune Group, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade
Sangamo Therapeutics, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade